Skip to main content

Table 3 Treatment Modalities of 83 Chinese Patients with PGL

From: Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

Treatment modalities Number of patients Histological Subtypes
(no. of patients)
Lugano Staging
(no. of patients)
   B-cell lymphoma
(n = 75)
T-cell
lymphoma
(n = 8)
I-II1
(n = 29)
II2-IV
(n = 54)
Single therapy 32 30 2 16 16
   Surgery 1 1 0 0 1
   Chemotherapy 29 27 2 14 15
   H. pylori eradication 2 2 0 2 0
Combined therapy 45 40 5 13 32
   Surgery + chemotherapy 23 20 3 6 17
   Surgery + chemotherapy + H. pylori eradication 2 1 1 1 1
   Chemotherapy + radiotherapy 14 13 1 3 11
   Chemotherapy + radiotherapy + H. pylori eradication 4 4 0 3 1
   Surgery + chemotherapy + radiotherapy 2 2 0 0 2
Supportive care only 6 5 1 2 4
Treatment in both single and combined therapy      
   Surgery 28 24 4 7 21
   Chemotherapy 74 67 7 27 47
   Radiotherapy 20 19 1 6 14
   H. pylori eradication 8 7 1 6 2